These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 8386682)
21. Reduced levels of messenger ribonucleic acid for calcium channel, glucose transporter-2, and glucokinase are associated with alterations in insulin secretion in fasted rats. Iwashima Y; Kondoh-Abiko A; Seino S; Takeda J; Eto M; Polonsky KS; Makino I Endocrinology; 1994 Sep; 135(3):1010-7. PubMed ID: 8070343 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase. Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930 [TBL] [Abstract][Full Text] [Related]
23. Glucokinase and NIDDM. A candidate gene that paid off. Permutt MA; Chiu KC; Tanizawa Y Diabetes; 1992 Nov; 41(11):1367-72. PubMed ID: 1397713 [TBL] [Abstract][Full Text] [Related]
24. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Gidh-Jain M; Takeda J; Xu LZ; Lange AJ; Vionnet N; Stoffel M; Froguel P; Velho G; Sun F; Cohen D Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1932-6. PubMed ID: 8446612 [TBL] [Abstract][Full Text] [Related]
25. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Matschinsky FM Diabetes; 1996 Feb; 45(2):223-41. PubMed ID: 8549869 [TBL] [Abstract][Full Text] [Related]
26. Present and potential future use of gene therapy for the treatment of non-insulin dependent diabetes mellitus (Review). Freeman DJ; Leclerc I; Rutter GA Int J Mol Med; 1999 Dec; 4(6):585-92. PubMed ID: 10567666 [TBL] [Abstract][Full Text] [Related]
27. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Vionnet N; Stoffel M; Takeda J; Yasuda K; Bell GI; Zouali H; Lesage S; Velho G; Iris F; Passa P Nature; 1992 Apr; 356(6371):721-2. PubMed ID: 1570017 [TBL] [Abstract][Full Text] [Related]
28. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes. Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470 [TBL] [Abstract][Full Text] [Related]
29. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Velho G; Froguel P; Clement K; Pueyo ME; Rakotoambinina B; Zouali H; Passa P; Cohen D; Robert JJ Lancet; 1992 Aug; 340(8817):444-8. PubMed ID: 1354782 [TBL] [Abstract][Full Text] [Related]
30. [Genetic causes of type 2 diabetes]. Malm D Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1058-61. PubMed ID: 9531830 [TBL] [Abstract][Full Text] [Related]
31. Engineering of a glucose-responsive surrogate cell for insulin replacement therapy of experimental insulin-dependent diabetes. Tiedge M; Elsner M; McClenaghan NH; Hedrich HJ; Grube D; Klempnauer J; Lenzen S Hum Gene Ther; 2000 Feb; 11(3):403-14. PubMed ID: 10697115 [TBL] [Abstract][Full Text] [Related]
32. Molecular genetic analysis of NIDDM. Status and prospects. Poller W; Schatz H Exp Clin Endocrinol; 1993; 101(2):58-68. PubMed ID: 8405141 [No Abstract] [Full Text] [Related]
33. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns. Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619 [TBL] [Abstract][Full Text] [Related]
34. The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection. Lei L; Liu S; Li Y; Song H; He L; Liu Q; Sun S; Li Y; Feng Z; Shen Z Eur J Pharmacol; 2018 May; 826():17-23. PubMed ID: 29477658 [TBL] [Abstract][Full Text] [Related]
35. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720 [TBL] [Abstract][Full Text] [Related]
36. [Behavior of pancreatic beta-cells in type I and II diabetes: clinical implications?]. Waeber G Rev Med Suisse Romande; 1995 Sep; 115(9):627-34. PubMed ID: 7481346 [No Abstract] [Full Text] [Related]
37. Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose. Motoyoshi S; Shirotani T; Araki E; Sakai K; Kaneko K; Motoshima H; Yoshizato K; Shirakami A; Kishikawa H; Shichiri M Diabetologia; 1998 Dec; 41(12):1492-501. PubMed ID: 9867217 [TBL] [Abstract][Full Text] [Related]
38. The genetics of non-insulin-dependent diabetes mellitus. Pillay TS; Langlois WJ; Olefsky JM Adv Genet; 1995; 32():51-98. PubMed ID: 7741025 [No Abstract] [Full Text] [Related]
39. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Polonsky KS Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637 [TBL] [Abstract][Full Text] [Related]
40. Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus. Chiu KC; McCarthy JE Biochem Biophys Res Commun; 1996 Apr; 221(3):614-8. PubMed ID: 8630009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]